This topic will provide an overview of the principles and theories that guide ethical decision-making in the biomedical field, including autonomy, beneficence, non-maleficence, and justice.
Introduction to Biomedical Ethics
Key concepts, principles, and applications for health‑care professionals and students
| Aspect | Description |
|---|---|
| Definition | The systematic study of moral issues arising from the practice of medicine and biomedical research. |
| Scope | Clinical care, public‑health policy, research involving humans, genetics, end‑of‑life decisions, resource allocation, and emerging technologies (e.g., AI, CRISPR). |
| Goal | Provide a framework for making justified, transparent, and compassionate decisions that respect patients, families, and society. |
| Year | Event | Ethical Impact |
|---|---|---|
| 1947 | Nuremberg Code (post‑WWII trials) | First formal statement on voluntary consent and the duty to avoid unnecessary suffering in research. |
| 1964 | Declaration of Helsinki (World Medical Association) | Global guidelines for clinical research ethics. |
| 1979 | Belmont Report (U.S.) | Introduced the three core principles: Respect for Persons, Beneficence, Justice. |
| 1990 | The Ethics of Human Genome Project | Sparked debate on privacy, consent, and genetic discrimination. |
| 2000s | Rise of bioethics committees and institutional review boards (IRBs) | Institutionalized ethical oversight in hospitals and universities. |
| 2020‑2024 | COVID‑19 pandemic | Highlighted issues of equitable vaccine distribution, triage, and data privacy. |
| Principle | Core Idea | Typical Questions |
|---|---|---|
| Respect for Autonomy | Individuals have the right to make informed choices about their own bodies and health. | • Has the patient received adequate information? • Are there coercive influences? |
| Beneficence | Actively promote the well‑being of patients and research participants. | • Does the intervention provide a net benefit? • How can we maximize positive outcomes? |
| Non‑maleficence | “Do no harm.” Avoid causing injury or unnecessary risk. | • What are the potential harms? • Are risks proportionate to benefits? |
| Justice | Fair distribution of benefits, risks, and resources. | • Who gets access to a new therapy? • Are vulnerable groups protected from exploitation? |
Note: In practice, these principles often conflict; ethical deliberation seeks a balanced resolution.
| Domain | Typical Issues | Ethical Tools |
|---|---|---|
| Clinical Decision‑Making | Informed consent, refusal of treatment, advance directives, surrogate decision‑making. | Shared decision‑making models; decision aids. |
| End‑of‑Life Care | Palliative care, physician‑assisted dying, withdrawal of life‑support. | “Four‑principle” analysis; palliative ethics frameworks. |
| Genetics & Genomics | Genetic testing, prenatal screening, gene editing, data privacy. | Genetic counseling ethics; “right not to know.” |
| Research Ethics | Human subjects protection, placebo use, data falsification, conflict of interest. | Institutional Review Boards (IRBs); Good Clinical Practice (GCP). |
| Public Health | Vaccination policies, quarantine, resource allocation during pandemics. | Utilitarian reasoning; “least restrictive means” principle. |
| Emerging Technologies | AI diagnostics, nanomed |